Uber, Abiomed, Peloton, Carvana, Molson Coors and more
CFO News Room
NOVEMBER 1, 2022
Pfizer – Shares of the pharmaceutical giant jumped nearly 3% after the company reported stronger-than-expected earnings and issued an improved financial outlook. Deutsche Bank reiterated the stock as a buy and said it was well positioned, but did concede that macro challenges were challenging advertising budgets. billion forecast.
130 
Let's personalize your content